Advancing how real world impact is assessed
Award-winning BMJ Impact Analytics* is the most up-to-date and comprehensive tool you can use to track and share the real-world impact of your medical and health research. If you fund, publish or produce research or policy, BMJ Impact Analytics tracks where it’s cited in Clinical Guidance and Health Policy worldwide.
Developed by BMJ in collaboration with pioneering start-up Overton, it is the only tool dedicated to health and social care, covering the greatest breadth of key medical sources. BMJ Impact Analytics uniquely shows the influence on patient treatment (citing BMJ’s leading decision support tool, BMJ Best Practice) and provides your impact in context.
*BMJ Impact Analytics received the ALPSP Award for Innovation in Publishing 2023
What makes BMJ Impact Analytics unique
-
Only tool focused on health and social care covering the greatest breadth of key medical sources
-
Uniquely shows how research influences patient care – shows citations in local guidelines, care pathways and in tools used by healthcare professionals to deliver care (BMJ Best Practice)
-
Provides context to impact in all document sources
-
Shows links between health policy documents and grey literature
-
Easy to use and extensively tested – developed in partnership with medical departments at universities and funders of medical research
Learn about our latest developments and upcoming enhancements
Since launch we have continued to engage with funders, universities and researchers worldwide to understand their challenges around real-world impact and to ensure that BMJ Impact Analytics continues to innovate and evolve to meet their needs.
Find out about our latest developments and what’s coming up in 2024.
How is BMJ Impact Analytics different from Overton?
Our co-development combines Overton’s data knowledge and BMJ’s health expertise to offer the only impact tool focused on health and social care. Read about our collaboration and the differences between the two products.
We chose to partner with BMJ because of their expertise and reach in the medical research community. Their existing relationships and global presence made the organisation a valuable partner. Additionally, BMJ’s mission-driven approach aligned with our values at Overton.”
Euan AdieFounder and Director, Overton
Our commitment to responsible metrics
As a signatory of the San Francisco Declaration on Research Assessment (DORA), BMJ supports using multiple measures and metrics to portray impact. Across our products, where relevant, we are committed to abiding by DORA’s framework.
What does this mean for data in BMJ Impact Analytics?
We are open and transparent about the scope of our data and its limitations. Our Responsible Metrics feature provides you with detailed information on the caveats and limitations of the data so that you can understand how to interpret the evidence of real word impact.
For more detailed information, please get in touch with us.
Understanding the impact of our research on healthcare policy-making globally would be impossible without BMJ Impact Analytics. The scale and depth of information we can access, and the ease with which we can navigate it, is hugely impressive. The value of this tool goes far beyond discovering where we are cited. We see it playing a major role in identifying future collaborators as well as additional avenues for sharing our research. All of this will enhance our ability to make meaningful contributions to the field of healthcare research and positively impact patient care worldwide.”
Tim Watson, Director of Marketing & Communications, Office of Health Economics (OHE)